Vertex Pharmaceuticals, Inc. (NASDAQ:VRTX)

CAPS Rating: 3 out of 5

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.

Recs

0
Player Avatar gertmoller (< 20) Submitted: 2/11/2011 7:18:31 AM : Outperform Start Price: $37.93 VRTX Score: +70.77

Life changing research

Report this Post Reply

Featured Broker Partners


Advertisement